Gero
PrivateLast Round
Series A
Extension
Oct 18, 2023
Total Funding Raised
$8.2M
Momentum Score
25 /100
Company Overview
Gero is a preclinical-stage biotechnology company that utilizes a physics-informed artificial intelligence platform to analyze real-world human health data. The company's mission is to decode the relationship between aging and chronic diseases to discover novel therapeutics. By modeling the aging process, Gero aims to identify targets that can restore systemic resilience, delay disease, and extend healthy human lifespan. The company pursues a dual business model, advancing its own in-house drug development programs while also forming research collaborations with major pharmaceutical companies, such as Pfizer and Chugai, to discover new drug targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gero Comps
Public and private peers based on sector, stage, and business model.
Gero Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 18, 2023 | ||||
| Series A | Aug 4, 2020 |
Key People
Founding team and executive leadership
Gero Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TOP Venture | Series A |
| VitaDAO | Series A Extension |
| Melnichek Investments | Series A Extension |
| Bulba Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2025
Brian Kennedy appointed to the Board of Directors.
- Jul 8, 2025
Partnered with Chugai to develop novel therapies for age-related diseases.
Gero Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gero's valuation, stock price, and market status.
